tradingkey.logo
tradingkey.logo
Suchen

AngioDynamics Inc

ANGO
Zur Watchlist hinzufügen
13.090USD
+0.010+0.08%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
545.62MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über AngioDynamics Inc Unternehmen

AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. Its product categories include oncology, venous therapies, vascular interventions, and ports. Its oncology products include Model 1500X RF Generator, IsoLoc Endorectal Balloon, Habib 4X Laparoscopic Bipolar Resection Device, Habib 4X Bipolar Resection Device, and Alatus. Its venous therapies include VenaCure EVLT 1470 Pro Laser, VenaCure EVLT System, VenaCure EVLT Procedure Packs, and others.

AngioDynamics Inc Informationen

BörsenkürzelANGO
Name des UnternehmensAngioDynamics Inc
IPO-datumMay 27, 2004
CEOClemmer (James C)
Anzahl der mitarbeiter675
WertpapierartOrdinary Share
GeschäftsjahresendeMay 27
Addresse14 Plaza Drive
StadtLATHAM
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl12110
Telefon15187981215
Websitehttps://www.angiodynamics.com/
BörsenkürzelANGO
IPO-datumMay 27, 2004
CEOClemmer (James C)

Führungskräfte von AngioDynamics Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Independent Director
Independent Director
--
--
Mr. Warren G. Nighan
Mr. Warren G. Nighan
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
Senior Vice President - Global Supply Chain, Quality and Regulatory Affairs
--
--
Mr. Chad T. Campbell
Mr. Chad T. Campbell
Senior Vice President, General Manager - Global Oncology and Vascular Access
Senior Vice President, General Manager - Global Oncology and Vascular Access
--
--
Ms. Karen A. Licitra
Ms. Karen A. Licitra
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Stephen A. Trowbridge, J.D.
Mr. Stephen A. Trowbridge, J.D.
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
323.32K
+0.28%
Mr. Howard W. Donnelly
Mr. Howard W. Donnelly
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
167.05K
--
Ms. Eileen O'Shea Auen
Ms. Eileen O'Shea Auen
Independent Director
Independent Director
129.72K
--
Ms. Laura Piccinini
Ms. Laura Piccinini
Senior Vice President, General Manager - Endovascular Therapies and International
Senior Vice President, General Manager - Endovascular Therapies and International
102.52K
-35.34%
Mr. Wesley E. Johnson, Jr.
Mr. Wesley E. Johnson, Jr.
Independent Director
Independent Director
--
--
Mr. James C. Clemmer
Mr. James C. Clemmer
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von AngioDynamics Inc?

Die fünf größten Anteilseigner von AngioDynamics Inc sind: Mr. Stephen A. Trowbridge, J.D.

Wie viele Institutionen halten Anteile an AngioDynamics Inc (ANGO)?

Mit Stand vom 2026Q1 halten 321 Institutionen Anteile an AngioDynamics Inc, mit einem Gesamtmarktwert von etwa 38.82M, was 93.94% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -7218201.00 gestiegen.